COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir

The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.

from Zee News :India National https://ift.tt/2Bq9aCs